Event info
Date:21 Sep
Time: 08:30 to 13:00
Venue:

Boost Seminar – Early Clinical Development in the Nordic Countries

The Nordic arena for early clinical trials attracts pharmaceutical companies from all over the world. What they seek is high quality trials performed by high performing sites. What can the Nordic countries provide and how can companies within the Medicon Valley make best use of the expertise available right on our doorstep? This seminar aims to show a pallet of opportunities and how to make best use of them.
The Nordic Countries is an excellent region for running early clinical trials. The competence, the mentality, the flexibility and the will is very strong in this area. The cooperation between Research Groups, The Health Care and the Pharmaceutical and CRO industry also works very well.
This seminar is interesting for you if you are involved in early clinical development or if you are about to start your first clinical trials and want to learn more about your different options. It will also be possible to get an in depth understanding in early clinical research from two well known researchers in the area of Oncology and CNS/Neurology.
Welcome to a seminar to boost your knowledge within early clinical delevopment.

Date & Time: Friday 21 September 2012, 8:30-13:00
Venue: Edvard Thomsens Vej 10, 2300 Copenhagen S, Denmark
Room: Auditorium
Price:
MVA members free of charge (no-show/late cancellation fee DKK 1.000 ex VAT)
Non-members DKK 2.500 ex. VAT (become a member here)
Will be invoiced prior to the seminar.
Register: To register please go to the bottom of this page.
In collaboration with:

Program

08:30Registration, coffee and networking
09:00Introduction & Welcome
Tina Thuesen, Unit Manager, TFS Denmark
09:10How to prepare for a successful Phase I trial
Harriet Hansson, Medical Advisor, TFS
09:40Early clinical research in Oncology
Prof. Steinar Aamdal, MD and Prof. Paal Fr. Brunsvig, MD, Oslo University Hospital, Department of Clinical Cancer Research
10:20Coffee break and networking
10:40Positron Emission Tomography in drug development
Per Stenkrona, MD, Project Manager, Karolinska Institutet  
11:20Running early clinical development in the Nordic Countries
Helene Rahdevi, Unit Manager, TFS Develop & Explore
12:00Questions & closing remarks
12:20Lunch and networking

About TFS:
TFS was started in 1996 and has since then grown to be the largest non listed CRO in Europe and the largest CRO in the Nordic Countries. The Company is privately owned by Daniel Spasic. TFS is a mid size CRO that can offer European and Global solutions with local service and flexibility. TFS is a full service CRO and operates in four business areas:

  • TFS Explore: Early clinical development
  • TFS Develop: Clinical Operations from Phase II to Phase IV
  • TFS People: Medical & Clinical Staffing
  • TFS Academy: Training & Education in Clinical Development

Register:
Please register by filling in the form below, latest Tuesday 18 September.
We use the input data as it is written for name tags and list of participants, and the email for further information prior to the Boost Seminar.
Registration has been closed